FindTrial
Sign In

Cost-effectiveness of nitrendipine plus hydrochlorothiazide or metoprolol in the treatment of hypertension

Key technology integration and application research of cardio-cerebrovascular disease prevention in rural China

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-15006718
Enrollment
Unknown
Registered
2015-07-09
Start date
2013-07-14
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

2:antihypertension regents

Sponsors

National center for cardiovascular diseases Fuwai hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: This study enrolled outpatient males and females 18-70 years-old who had stage 2 systolic hypertension (systolic BP >= 160mmHg and/or diastolic BP >=100mmHg).

Exclusion criteria

Exclusion criteria: Patients were excluded if who pregnant, myocardiol infarction, chronic kidney disease, congestive heart failure, coronary artery disease, cerebrovascular disease, Type 1 diabetes mellitus(DM) or uncontrolled type 2 DM (Glucose > 11mmol/L) or refused to undergo follow-up visits. Other key exclusion criteria were systolic BP above 200 mmHg or diastolic BP above 110 mmHg at the time of enrollment, secondary hypertension, or resistant hypertension.

Design outcomes

Primary

MeasureTime frame
Blood;—

Countries

China

Contacts

Public Contactwang zengwu
wangzengwu@foxmail.com+86 139601366932

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026